-
Innovation Ranking
NewInnovation Ranking – S&P Global Inc
S&P Global Inc (SPGI) is a provider of financial intelligence solutions. It offers credit ratings, benchmarks, data, and digital and traditional financial research and analytical tools to the capital and commodity markets globally. The company provides cross-asset analytics, multi-asset-class data, benchmark prices, desktop services, and investment information. SPGI is a provider of information and benchmark prices for the commodity and energy markets. It also maintains various valuation and index benchmarks for wealth managers, investment advisors, and institutional investors. The company...
-
Innovation Ranking
NewInnovation Ranking – Zhong An Online P&C Insurance Co., Ltd
Zhong An Online P&C Insurance Co Ltd (Zhong An) is a provider of online insurance services. The company's offerings include health insurance, bond insurance, accident insurance, motor insurance, credit insurance, cargo insurance, liability insurance, household property insurance and shipping return insurance. Through its subsidiary, the company provides technology solutions and data analytics and information in the domestic and overseas insurance industry. Zhong An is headquartered in Shanghai, China.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-CD19CD20-ALLO1 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-CD19CD20-ALLO1 in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-CD19CD20-ALLO1 in Follicular Lymphoma Drug Details: P-CD19CD20-ALL01 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-MUC1C-ALLO1 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-MUC1C-ALLO1 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-MUC1C-ALLO1 in Ovarian Cancer Drug Details: P-MUC1CALLO-1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-MUC1C-ALLO1 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-MUC1C-ALLO1 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-MUC1C-ALLO1 in Colorectal Cancer Drug Details: P-MUC1CALLO-1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-MUC1C-ALLO1 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-MUC1C-ALLO1 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-MUC1C-ALLO1 in Gastric Cancer Drug Details: P-MUC1CALLO-1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-MUC1C-ALLO1 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-MUC1C-ALLO1 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-MUC1C-ALLO1 in Solid Tumor Drug Details: P-MUC1CALLO-1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-MUC1C-ALLO1 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-MUC1C-ALLO1 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-MUC1C-ALLO1 in Esophageal Cancer Drug Details: P-MUC1CALLO-1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-MUC1C-ALLO1 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-MUC1C-ALLO1 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-MUC1C-ALLO1 in Pancreatic Cancer Drug Details: P-MUC1CALLO-1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-CD19CD20-ALLO1 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-CD19CD20-ALLO1 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-CD19CD20-ALLO1 in Mantle Cell Lymphoma Drug Details: P-CD19CD20-ALL01 is under...